(b) Flow cytometry analysis of single-cell suspension liver metastasis, comparing treatment of UM22 TILs and UM22 MART1-specific TILs for CD3+, CD3+CD8+CD69+, or CD3+CD8+CD137+. This evidence concerns the gene MLANA and medical procedure.